栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/01 | 1,944 | 1,950 | 1,920 | 1,950 | +40 | +2.1% | 183,600 |
2021/10/29 | 1,911 | 1,946 | 1,901 | 1,910 | +10 | +0.5% | 249,700 |
2021/10/28 | 1,920 | 1,930 | 1,881 | 1,900 | -101 | -5% | 532,400 |
2021/10/27 | 2,000 | 2,015 | 1,986 | 2,001 | +27 | +1.4% | 270,100 |
2021/10/26 | 1,982 | 1,987 | 1,970 | 1,974 | -4 | -0.2% | 184,900 |
2021/10/25 | 1,980 | 1,981 | 1,963 | 1,978 | -6 | -0.3% | 131,400 |
2021/10/22 | 1,974 | 1,999 | 1,973 | 1,984 | +9 | +0.5% | 89,800 |
2021/10/21 | 1,995 | 1,999 | 1,971 | 1,975 | -20 | -1% | 166,500 |
2021/10/20 | 2,003 | 2,015 | 1,991 | 1,995 | +9 | +0.5% | 171,300 |
2021/10/19 | 1,936 | 1,990 | 1,933 | 1,986 | +54 | +2.8% | 245,700 |
2021/10/18 | 1,952 | 1,954 | 1,919 | 1,932 | -10 | -0.5% | 139,900 |
2021/10/15 | 1,924 | 1,943 | 1,910 | 1,942 | +40 | +2.1% | 94,000 |
2021/10/14 | 1,908 | 1,914 | 1,888 | 1,902 | -13 | -0.7% | 138,900 |
2021/10/13 | 1,920 | 1,930 | 1,911 | 1,915 | +3 | +0.2% | 159,200 |
2021/10/12 | 1,938 | 1,939 | 1,909 | 1,912 | -27 | -1.4% | 139,500 |
2021/10/11 | 1,933 | 1,943 | 1,906 | 1,939 | -6 | -0.3% | 203,300 |
2021/10/08 | 1,947 | 1,956 | 1,930 | 1,945 | +26 | +1.4% | 123,200 |
2021/10/07 | 1,967 | 1,980 | 1,916 | 1,919 | -28 | -1.4% | 219,600 |
2021/10/06 | 1,981 | 1,996 | 1,942 | 1,947 | -12 | -0.6% | 182,100 |
2021/10/05 | 1,991 | 1,997 | 1,951 | 1,959 | -64 | -3.2% | 194,200 |
2021/10/04 | 2,075 | 2,076 | 2,012 | 2,023 | -32 | -1.6% | 104,200 |
2021/10/01 | 2,094 | 2,100 | 2,039 | 2,055 | -50 | -2.4% | 196,900 |
2021/09/30 | 2,102 | 2,137 | 2,095 | 2,105 | -14 | -0.7% | 168,800 |
2021/09/29 | 2,135 | 2,135 | 2,089 | 2,119 | -63 | -2.9% | 255,600 |
2021/09/28 | 2,192 | 2,193 | 2,155 | 2,182 | -10 | -0.5% | 148,900 |
2021/09/27 | 2,239 | 2,241 | 2,191 | 2,192 | -59 | -2.6% | 125,700 |
2021/09/24 | 2,248 | 2,260 | 2,228 | 2,251 | +43 | +1.9% | 120,000 |
2021/09/22 | 2,256 | 2,256 | 2,208 | 2,208 | -41 | -1.8% | 121,700 |
2021/09/21 | 2,264 | 2,265 | 2,232 | 2,249 | -46 | -2% | 108,500 |
2021/09/17 | 2,291 | 2,306 | 2,263 | 2,295 | +6 | +0.3% | 130,600 |
2021/09/16 | 2,297 | 2,301 | 2,266 | 2,289 | +8 | +0.4% | 124,500 |
2021/09/15 | 2,278 | 2,290 | 2,262 | 2,281 | -18 | -0.8% | 94,500 |
2021/09/14 | 2,278 | 2,300 | 2,259 | 2,299 | +23 | +1% | 122,800 |
2021/09/13 | 2,241 | 2,278 | 2,241 | 2,276 | +37 | +1.7% | 97,000 |
2021/09/10 | 2,211 | 2,240 | 2,186 | 2,239 | +12 | +0.5% | 163,800 |
2021/09/09 | 2,248 | 2,251 | 2,213 | 2,227 | -37 | -1.6% | 130,700 |
2021/09/08 | 2,261 | 2,276 | 2,252 | 2,264 | -6 | -0.3% | 114,300 |
2021/09/07 | 2,281 | 2,288 | 2,260 | 2,270 | -24 | -1% | 153,800 |
2021/09/06 | 2,279 | 2,294 | 2,264 | 2,294 | +32 | +1.4% | 100,500 |
2021/09/03 | 2,233 | 2,268 | 2,219 | 2,262 | +45 | +2% | 121,500 |
2021/09/02 | 2,190 | 2,225 | 2,181 | 2,217 | +38 | +1.7% | 195,000 |
2021/09/01 | 2,141 | 2,179 | 2,135 | 2,179 | +33 | +1.5% | 203,700 |
2021/08/31 | 2,141 | 2,161 | 2,137 | 2,146 | -6 | -0.3% | 85,900 |
2021/08/30 | 2,150 | 2,158 | 2,140 | 2,152 | +8 | +0.4% | 61,900 |
2021/08/27 | 2,152 | 2,157 | 2,136 | 2,144 | -23 | -1.1% | 93,100 |
2021/08/26 | 2,164 | 2,174 | 2,149 | 2,167 | +13 | +0.6% | 72,900 |
2021/08/25 | 2,153 | 2,165 | 2,145 | 2,154 | -5 | -0.2% | 95,700 |
2021/08/24 | 2,124 | 2,159 | 2,120 | 2,159 | +39 | +1.8% | 99,900 |
2021/08/23 | 2,118 | 2,156 | 2,118 | 2,120 | +19 | +0.9% | 182,600 |
2021/08/20 | 2,117 | 2,147 | 2,094 | 2,101 | -10 | -0.5% | 140,600 |
751~
800
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム